PLEASE NOTE

Due to severe weather conditions in the Dallas area, The Dallas CVI symposium is being rescheduled to take place on January 18, 2014

DIRECTORS

  • Subhash Banerjee , MD
    Chief, Division of Cardiology and VA North Texas Healthcare System Associate Professor of Medicine University of Texas Southwestern Medical School Dallas, Texas
  • Emmanouil Brilakis , MD, PhD
    Director Cardiac Catheterization Laboratories VA North Texas Healthcare System Associate Professor of Medicine University of Texas Southwestern Medical School Dallas, Texas

Symposium Overview

Cardiovascular disease is the number one cause of death in the United States. Percutaneous coronary interventions and stents have revolutionized the treatment of coronary artery disease and improved patient outcomes. However, these interventions have also created new challenges related to vessel healing and extended need for antiplatelet therapy. Similarly, peripheral, structural and anti-arrhythmic heart interventions are starting to reshape the treatment of heart disease. There is an essential need to make available updated information on the most current diagnostic and treatment strategies for coronary,  peripheral, structural and arrhythmic disease for interventional cardiologists, clinical cardiologists, scientists, and other health care providers and investigators who participate in the management of these  patients. The overarching goal of the “Dallas Cardiovascular Innovations 2015” symposium will be to improve awareness and understanding of the most current diagnostic and treatment strategies for  cardiovascular disease.

TARGET AUDIENCE

This course is designed for Interventional Cardiologists, Clinical Cardiologists, Internists, Residents, Fellows in Training, Nurses, Nurse Practitioners, Physician Assistants, Pharmacists and other Health Care Providers and Investigators who participate in the management of patients with coronary, peripheral and structural cardiovascular diseases.

EDUCATIONAL OBJECTIVES

Upon completion of this course, participants should be able to:

  • Recognize high-risk subsets of patients and tailor therapeutic interventions.
  • Define state-of-the-art management of patients with peripheral vascular disease.
  • Coronary artery disease, valvular heart disease, and arrhythmic heart disease.
  • Implement a guideline-based approach to patients with heart disease.

 

Accredited by:

Jointly Sponsored By: